Auteurs

David Mulder

Collaborateur senior

Read More

Christian Dekoninck

Associé

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Patrick Boháček

Collaborateur

Read More

Agnieszka Sztoldman

Collaborateur senior

Read More
Auteurs

David Mulder

Collaborateur senior

Read More

Christian Dekoninck

Associé

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Patrick Boháček

Collaborateur

Read More

Agnieszka Sztoldman

Collaborateur senior

Read More

9 novembre 2020

Pharmaceutical patent law – 1 de 2 Publications

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

  • Quick read

What is the role of patent law in emergency situations like the current coronavirus pandemic? And what exceptions to the law are there under such circumstances?

In the first article of our two-part series written for the European Intellectual Property Review, our international team consider these questions and more on both a broad, European level and from the perspective of six national jurisdictions.

Read the article here

Dans cette série

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Brexit

Brexit – what's the deal for business?

12 janvier 2021
Briefing

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

8+2+1 plus what? How UK data and market exclusivity rights will be affected from 1 January 2021

3 décembre 2020
Briefing

par Alison Dennis et Paul England, DPhil

Cliquer ici pour en savoir plus
Brevets et innovation

Reloaded: How UK supplementary protection certificates will change from 1 January 2021

24 novembre 2020
Briefing

par Paul England, DPhil

Cliquer ici pour en savoir plus